The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Carboplatin and paclitaxel as first-line treatment of unresectable or metastatic esophageal or gastric cancer.
Gopi Kesaria Prithviraj
No relevant relationships to disclose
Kathryn Anissa Baksh
No relevant relationships to disclose
William J. Fulp
No relevant relationships to disclose
Kenneth L. Meredith
No relevant relationships to disclose
Sarah E. Hoffe
No relevant relationships to disclose
Ravi Shridhar
No relevant relationships to disclose
Khaldoun Almhanna
No relevant relationships to disclose